A citation-based method for searching scientific literature

Monica Andrade Lima Gabbay, Melanie Rodacki, Luis Eduardo Calliari, Andre Gustavo Daher Vianna, Marcio Krakauer, Mauro Scharf Pinto, Janice Sepúlveda Reis, Marcia Puñales, Leonardo Garcia Miranda, Ana Claudia Ramalho, Denise Reis Franco, Hermelinda Pedrosa Cordeiro Pedrosa. Diabetol Metab Syndr 2020
Times Cited: 8







List of co-cited articles
35 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range.
Tadej Battelino, Thomas Danne, Richard M Bergenstal, Stephanie A Amiel, Roy Beck, Torben Biester, Emanuele Bosi, Bruce A Buckingham, William T Cefalu, Kelly L Close,[...]. Diabetes Care 2019
422
87

International Consensus on Use of Continuous Glucose Monitoring.
Thomas Danne, Revital Nimri, Tadej Battelino, Richard M Bergenstal, Kelly L Close, J Hans DeVries, Satish Garg, Lutz Heinemann, Irl Hirsch, Stephanie A Amiel,[...]. Diabetes Care 2017
496
62


Validation of Time in Range as an Outcome Measure for Diabetes Clinical Trials.
Roy W Beck, Richard M Bergenstal, Tonya D Riddlesworth, Craig Kollman, Zhaomian Li, Adam S Brown, Kelly L Close. Diabetes Care 2019
149
50



The Relationships Between Time in Range, Hyperglycemia Metrics, and HbA1c.
Roy W Beck, Richard M Bergenstal, Peiyao Cheng, Craig Kollman, Anders L Carlson, Mary L Johnson, David Rodbard. J Diabetes Sci Technol 2019
81
37


The Relationship of Hemoglobin A1C to Time-in-Range in Patients with Diabetes.
Robert A Vigersky, Chantal McMahon. Diabetes Technol Ther 2019
77
37

The Performance and Usability of a Factory-Calibrated Flash Glucose Monitoring System.
Timothy Bailey, Bruce W Bode, Mark P Christiansen, Leslie J Klaff, Shridhara Alva. Diabetes Technol Ther 2015
269
25

Glucose time in range and peripheral neuropathy in type 2 diabetes mellitus and chronic kidney disease.
Laura Mayeda, Ronit Katz, Iram Ahmad, Nisha Bansal, Zona Batacchi, Irl B Hirsch, Nicole Robinson, Dace L Trence, Leila Zelnick, Ian H de Boer. BMJ Open Diabetes Res Care 2020
11
25

Does Time-in-Range Matter? Perspectives From People With Diabetes on the Success of Current Therapies and the Drivers of Improved Outcomes.
Ava S Runge, Lynn Kennedy, Adam S Brown, Abigail E Dove, Brian J Levine, Sophie P Koontz, Varun S Iyengar, Sarah A Odeh, Kelly L Close, Irl B Hirsch,[...]. Clin Diabetes 2018
31
25

Association of Time in Range, as Assessed by Continuous Glucose Monitoring, With Diabetic Retinopathy in Type 2 Diabetes.
Jingyi Lu, Xiaojing Ma, Jian Zhou, Lei Zhang, Yifei Mo, Lingwen Ying, Wei Lu, Wei Zhu, Yuqian Bao, Robert A Vigersky,[...]. Diabetes Care 2018
104
25


Continuous Glucose Monitoring Sensors for Diabetes Management: A Review of Technologies and Applications.
Giacomo Cappon, Martina Vettoretti, Giovanni Sparacino, Andrea Facchinetti. Diabetes Metab J 2019
27
25

Continuous glucose monitoring: A review of the technology and clinical use.
David C Klonoff, David Ahn, Andjela Drincic. Diabetes Res Clin Pract 2017
65
25

Glycaemic variability: The under-recognized therapeutic target in type 1 diabetes care.
Emma G Wilmot, Pratik Choudhary, Lalantha Leelarathna, Mike Baxter. Diabetes Obes Metab 2019
9
25

FreeStyle Libre and Dexcom G4 Platinum sensors: Accuracy comparisons during two weeks of home use and use during experimentally induced glucose excursions.
F Boscari, S Galasso, A Facchinetti, M C Marescotti, V Vallone, A M L Amato, A Avogaro, D Bruttomesso. Nutr Metab Cardiovasc Dis 2018
25
25




Time in Specific Glucose Ranges, Glucose Management Indicator, and Glycemic Variability: Impact of Continuous Glucose Monitoring (CGM) System Model and Sensor on CGM Metrics.
Stefan Pleus, Ulrike Kamecke, Delia Waldenmaier, Manuela Link, Eva Zschornack, Nina Jendrike, Cornelia Haug, Guido Freckmann. J Diabetes Sci Technol 2020
3
66

Glucose Management Indicator (GMI): A New Term for Estimating A1C From Continuous Glucose Monitoring.
Richard M Bergenstal, Roy W Beck, Kelly L Close, George Grunberger, David B Sacks, Aaron Kowalski, Adam S Brown, Lutz Heinemann, Grazia Aleppo, Donna B Ryan,[...]. Diabetes Care 2018
110
25

Continuous Glucose Monitoring: A Brief Review for Primary Care Practitioners.
Ramzi Ajjan, David Slattery, Eugene Wright. Adv Ther 2019
12
25

Discrepancies between methods of continuous glucose monitoring in key metrics of glucose control in children with type 1 diabetes.
Arkadiusz Michalak, Konrad Pagacz, Wojciech Młynarski, Agnieszka Szadkowska, Wojciech Fendler. Pediatr Diabetes 2019
7
28


System accuracy evaluation of 18 CE-marked current-generation blood glucose monitoring systems based on EN ISO 15197:2015.
Stefan Pleus, Annette Baumstark, Nina Jendrike, Jochen Mende, Manuela Link, Eva Zschornack, Cornelia Haug, Guido Freckmann. BMJ Open Diabetes Res Care 2020
6
33

Continuous Glucose Monitoring vs Conventional Therapy for Glycemic Control in Adults With Type 1 Diabetes Treated With Multiple Daily Insulin Injections: The GOLD Randomized Clinical Trial.
Marcus Lind, William Polonsky, Irl B Hirsch, Tim Heise, Jan Bolinder, Sofia Dahlqvist, Erik Schwarz, Arndís Finna Ólafsdóttir, Anders Frid, Hans Wedel,[...]. JAMA 2017
227
25

Effect of Continuous Glucose Monitoring on Glycemic Control in Adults With Type 1 Diabetes Using Insulin Injections: The DIAMOND Randomized Clinical Trial.
Roy W Beck, Tonya Riddlesworth, Katrina Ruedy, Andrew Ahmann, Richard Bergenstal, Stacie Haller, Craig Kollman, Davida Kruger, Janet B McGill, William Polonsky,[...]. JAMA 2017
346
25

A Three-Way Accuracy Comparison of the Dexcom G5, Abbott Freestyle Libre Pro, and Senseonics Eversense Continuous Glucose Monitoring Devices in a Home-Use Study of Subjects with Type 1 Diabetes.
Rabab Z Jafri, Courtney A Balliro, Firas El-Khatib, Michele M Maheno, Mallory A Hillard, Alexander O'Donovan, Rajendranath Selagamsetty, Hui Zheng, Edward R Damiano, Steven J Russell. Diabetes Technol Ther 2020
6
33

Calibration of Minimally Invasive Continuous Glucose Monitoring Sensors: State-of-The-Art and Current Perspectives.
Giada Acciaroli, Martina Vettoretti, Andrea Facchinetti, Giovanni Sparacino. Biosensors (Basel) 2018
24
25

Toward Defining the Threshold Between Low and High Glucose Variability in Diabetes.
Louis Monnier, Claude Colette, Anne Wojtusciszyn, Sylvie Dejager, Eric Renard, Nicolas Molinari, David R Owens. Diabetes Care 2017
105
25

Lag Time Remains with Newer Real-Time Continuous Glucose Monitoring Technology During Aerobic Exercise in Adults Living with Type 1 Diabetes.
Dessi P Zaharieva, Kamuran Turksoy, Sarah M McGaugh, Rubin Pooni, Todd Vienneau, Trang Ly, Michael C Riddell. Diabetes Technol Ther 2019
26
25

Evidence of a strong association between frequency of self-monitoring of blood glucose and hemoglobin A1c levels in T1D exchange clinic registry participants.
Kellee M Miller, Roy W Beck, Richard M Bergenstal, Robin S Goland, Michael J Haller, Janet B McGill, Henry Rodriguez, Jill H Simmons, Irl B Hirsch. Diabetes Care 2013
236
25

Prevalence of cardiovascular disease risk factors in U.S. children and adolescents with diabetes: the SEARCH for diabetes in youth study.
Beatriz L Rodriguez, Wilfred Y Fujimoto, Elizabeth J Mayer-Davis, Giuseppina Imperatore, Desmond E Williams, Ronny A Bell, R Paul Wadwa, Shana L Palla, Lenna L Liu, Ann Kershnar,[...]. Diabetes Care 2006
139
25


Glycemic variability is higher in type 1 diabetes patients with microvascular complications irrespective of glycemic control.
Jan Šoupal, Jan Škrha, Martin Fajmon, Eva Horová, Miloš Mráz, Jan Škrha, Martin Prázný. Diabetes Technol Ther 2014
51
12


Interpretation and Impact of Real-World Clinical Data for the Practicing Clinician.
Lawrence Blonde, Kamlesh Khunti, Stewart B Harris, Casey Meizinger, Neil S Skolnik. Adv Ther 2018
87
12

Time in Range, as a Novel Metric of Glycemic Control, Is Reversely Associated with Presence of Diabetic Cardiovascular Autonomic Neuropathy Independent of HbA1c in Chinese Type 2 Diabetes.
Qingyu Guo, Pu Zang, Shaoying Xu, Wenjing Song, Zhen Zhang, Chunyan Liu, Zhanhong Guo, Jing Chen, Bin Lu, Ping Gu,[...]. J Diabetes Res 2020
12
12

Association between glucose variability as assessed by continuous glucose monitoring (CGM) and diabetic retinopathy in type 1 and type 2 diabetes.
Giovanni Sartore, Nino Cristiano Chilelli, Silvia Burlina, Annunziata Lapolla. Acta Diabetol 2013
60
12

Elucidating the Mechanism of Absorption of Fast-Acting Insulin Aspart: The Role of Niacinamide.
Jonas Kildegaard, Stephen T Buckley, Rasmus H Nielsen, Gro K Povlsen, Torben Seested, Ulla Ribel, Helle B Olsen, Svend Ludvigsen, Claus B Jeppesen, Hanne H F Refsgaard,[...]. Pharm Res 2019
19
12

A Randomized Trial Evaluating the Efficacy and Safety of Fast-Acting Insulin Aspart Compared With Insulin Aspart, Both in Combination With Insulin Degludec With or Without Metformin, in Adults With Type 2 Diabetes (ONSET 9).
Wendy S Lane, Elena Favaro, Naveen Rathor, Hak C Jang, Maiken I S Kjærsgaard, Alejandra Oviedo, Ludger Rose, Peter Senior, Giorgio Sesti, Alfonso Soto Gonzalez,[...]. Diabetes Care 2020
4
25


Reduction of postprandial hyperglycemia and frequency of hypoglycemia in IDDM patients on insulin-analog treatment. Multicenter Insulin Lispro Study Group.
J H Anderson, R L Brunelle, V A Koivisto, A Pfützner, M E Trautmann, L Vignati, R DiMarchi. Diabetes 1997
201
12

Glucose variability.
F John Service. Diabetes 2013
108
12

Fast-Acting Insulin Aspart Improves Glycemic Control in Basal-Bolus Treatment for Type 1 Diabetes: Results of a 26-Week Multicenter, Active-Controlled, Treat-to-Target, Randomized, Parallel-Group Trial (onset 1).
David Russell-Jones, Bruce W Bode, Christophe De Block, Edward Franek, Simon R Heller, Chantal Mathieu, Athena Philis-Tsimikas, Ludger Rose, Vincent C Woo, Anne Birk Østerskov,[...]. Diabetes Care 2017
73
12


A randomized, multicentre trial evaluating the efficacy and safety of fast-acting insulin aspart in continuous subcutaneous insulin infusion in adults with type 1 diabetes (onset 5).
David C Klonoff, Mark L Evans, Wendy Lane, Hans-Peter Kempe, Eric Renard, J Hans DeVries, Tina Graungaard, Agon Hyseni, Theis Gondolf, Tadej Battelino. Diabetes Obes Metab 2019
16
12

Adding fast-acting insulin aspart to basal insulin significantly improved glycaemic control in patients with type 2 diabetes: A randomized, 18-week, open-label, phase 3 trial (onset 3).
Helena W Rodbard, Devjit Tripathy, Maricela Vidrio Velázquez, Marek Demissie, Søren C Tamer, Milivoj Piletič. Diabetes Obes Metab 2017
27
12


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.